Poseida Therapeutics Inc (PSTX) Return on Investment ROI from the third quarter of 2024 to third quarter of 2023 and for the year 2024, average high and low, overall ranking from Sep 30 2024 to Sep 30 2023 - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Poseida Therapeutics Inc   (NASDAQ: PSTX)


Poseida Therapeutics Inc's ROI from its third quarter of 2024 to the third quarter of 2023 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Poseida Therapeutics Inc's ROI in the third quarter of 2024?
Poseida Therapeutics Inc recorded a cumulative net loss of $-61 million during 12 months ending in the third quarter of 2024, resulting in a negative return on investment (ROI) of -34.01%.

Within the Healthcare sector 404 other companies had a higher return on investment. While Return on investment, overall ranking has progressed in the Sep 30 2024 quarter, so far to 3472, from total ROI ranking in the second quarter of 2024 at 3692.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Sep 30 2024)
III. Quarter		 (Jun 30 2024)
II. Quarter		 (Mar 31 2024)
I. Quarter		 (Dec 31 2023)
IV. Quarter		 (Sep 30 2023)
III. Quarter
Y / Y Investment Change TTM -21.85 % -28.86 % -20.7 % -5.81 % 13.59 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 198 177 158 182 203
Return On Investment (TTM) -34.01 % -62.61 % -58.25 % -59.71 % -57.75 %
PSTX's Overall Ranking # 3472 # 3692 # 0 # 0 # 3936
Seq. Investment Change TTM -0.81 % -3.62 % -9.59 % -9.58 % -9.71 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -61 -113 -109 -123 -132

PSTX Company Profile >> Back to PSTX Roi Comparisons >> See Annual PSTX Return On Investment



Return On Investment PSTX's Ranking
Within: No.
Industry # 54
Sector # 405
Overall # 3472

Return On Investment Statistics
High Average Low
-10.6 %
-43.9 %
-68.81 %
(Jun 30 2023)   (Jun 30 2022)



  News about Poseida Therapeutics Inc Return on Investment ROI

Poseida Therapeutics Employs Dr. Syed Rizvi, M.D., as Chief Medical Officer, Navigating Share Value Decline Amid Promising Cell and Gene Therapy Advancements.

March 25, 2024

Poseida Therapeutics Appoints Syed Rizvi, M.D., as Chief Medical Officer; Shares Fall by 3.42% in a Challenging Market
SAN DIEGO, March 25, 2024 - Poseida Therapeutics, Inc. (Nasdaq: PSTX), a renowned clinical-stage cell and gene therapy company dedicated to revolutionizing treatments for cancer and rare diseases, has made a significant addition to its leadership team. Today, the company proudly announced the appointment of accomplished medical professional Syed Rizvi, M.D., as its Chief Medical Officer. While this announcement comes with great expectations for the future, Poseida Therapeutics also faces the challenge of a recent decline in share value.
Dr. Rizvi brings a wealth of expertise and experience to his new role at Poseida Therapeutics. With a distinguished background in clinical research and a specialization in oncology, he has played an integral part in numerous transformative therapy development programs. His deep understanding of the complexities of cancer treatment will undoubtedly propel Poseida Therapeutics mission forward.





Financial Statements
Poseida Therapeutics Inc's III. Quarter Investments $ 198 Millions PSTX's Balance sheet
Poseida Therapeutics Inc's III. Quarter Income $ 20 Millions Quarterly PSTX's Income Statement
PSTX's Income by Division See PSTX's Income by Division


PSTX Annual Return On Investment (Dec 31 2023)
2023		 (Dec 31 2022)
2022		 (Dec 31 2021)
2021		 (Dec 31 2020)
2020
Total Investments in Millions 182 269 196 301 0
Y / Y Investment Growth -32.53 % 37.09 % -34.78 % - -
Net Income in Millions -123 -64 -125 -130 0
Y / Y Net Income Growth - - - - -
Annual Return On Investment -67.94 % -23.77 % -63.62 % -43.09 % -


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Biotechnology & Pharmaceuticals Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
PSTX's Roi Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for PSTX's Competitors
Subscribers only: Roi for Poseida Therapeutics Inc's Suppliers
Subscribers only: Return On Investment for PSTX's Customers

Other Ratios
PSTX's Roa PSTX's Inventory Turnover Ratio PSTX's Growth Rates PSTX's Dividend Statistics
PSTX's Profitability Ratios PSTX's Asset Turnover Ratio PSTX's Dividend Growth
PSTX's Roe PSTX's Valuation Ratios PSTX's Financial Strength Ratios PSTX's Dividend Payout Ratio



Companies with similar Return On Investment at Sep 30 2024, within Healthcare Sector ROI

Date modified: 2026-09-18T13:11:05+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.